|
1
|
Varshavsky A: The ubiquitin system, an
immense realm. Annu Rev Biochem. 81:167–176. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schwartz AL and Ciechanover A: The
ubiquitin-proteasome pathway and pathogenesis of human diseases.
Annu Rev Med. 50:57–74. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xie Y: Feedback regulation of proteasome
gene expression and its implications in cancer therapy. Cancer
Metastasis Rev. 29:687–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Micel LN, Tentler JJ, Smith PG and
Eckhardt GS: Role of ubiquitin ligases and the proteasome in
oncogenesis: novel targets for anticancer therapies. J Clin Oncol.
31:1231–1238. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Orlowski RZ and Kuhn DJ: Proteasome
inhibitors in cancer therapy: lessons from the first decade. Clin
Cancer Res. 14:1649–1657. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Teicher BA, Ara G, Herbst R, Palombella VJ
and Adams J: The proteasome inhibitor PS-341 in cancer therapy.
Clin Cancer Res. 5:2638–2645. 1999.PubMed/NCBI
|
|
7
|
Voorhees PM and Orlowski RZ: The
proteasome and proteasome inhibitors in cancer therapy. Ann Rev
Pharmacol Toxicol. 46:189–213. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kumar A, Galeb S and Djulbegovic B:
Treatment of patients with multiple myeloma: an overview of
systematic reviews. Acta Haematol. 125:8–22. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gottesman MM: Mechanisms of cancer drug
resistance. Annu Rev Med. 53:615–627. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dimri GP: What has senescence got to do
with cancer? Cancer Cell. 7:505–512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mansilla S, Bataller M and Portugal J:
Mitotic catastrophe as a consequence of chemotherapy. Anticancer
Agents Med Chem. 6:589–602. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pan X, Ye P, Yuan DS, et al: A DNA
integrity network in the yeast Saccharomyces cerevisiae.
Cell. 124:1069–1081. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tong AH, Lesage G, Bader GD, et al: Global
mapping of the yeast genetic interaction network. Science.
303:808–813. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Giaever G, Flaherty P, Kumm J, et al:
Chemogenomic profiling: identifying the functional interactions of
small molecules in yeast. Proc Natl Acad Sci USA. 101:793–798.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ju D, Wang X and Xie Y: Dyclonine and
alverine citrate enhance the cytotoxic effects of proteasome
inhibitor MG132 on breast cancer cells. Intl J Mol Med. 23:205–209.
2009.PubMed/NCBI
|
|
16
|
Kuhn DJ, Chen Q, Voothees PM, et al:
Potent activity of carfilzomib, a novel, irreversible inhibitor of
the ubiquitin-proteasome pathway, against preclinical models of
multiple myeloma. Blood. 110:3281–3290. 2007. View Article : Google Scholar
|
|
17
|
Xu H, Ju D, Jarois T and Xie Y: Diminished
feedback regulation of proteasome expression and resistance to
proteasome inhibitors in breast cancer cells. Breast Cancer Res
Treat. 107:267–274. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Milano A, Iaffaioli RV and Caponigro F:
The proteasome: a worthwhile target for the treatment of solid
tumours? Eur J Cancer. 43:1125–1133. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lees ND, Skaggs B, Kirsch DR and Bard M:
Cloning of the late genes in the ergosterol biosynthetic pathway of
Saccharomyces cerevisiae - a review. Lipids. 30:221–226.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bennati AM, Castelli M, Fazia MA, et al:
Sterol dependent regulation of human TM7SF2 gene expression: role
of the encoded 3beta-hydroxysterol Delta14-reductase in human
cholesterol biosynthesis. Biochim Biophys Acta. 1761:677–668. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Holmer L, Pezhman A and Worman HJ: The
human lamin B receptor/sterol reductase multigene family. Genomics.
54:469–476. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meusser B, Hirsch C, Jarosch E and Sommer
T: ERAD: the long road to destruction. Nat Cell Biol. 7:766–772.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goldstein JL, DeBose-Boyd RA and Brown MS:
Protein sensors for membrane sterols. Cell. 124:35–46. 2006.
View Article : Google Scholar : PubMed/NCBI
|
